恩杂鲁胺 3 FDA does not approve talazoparib plus enzalutamide for non-HRR gene mutated mCRPC 2025/06/17 FDA不批准他拉唑帕利加恩杂鲁胺治疗非HRR基因突变的mCRPC 2025/06/17 Murilo De Almeida Luz, MD, on PSA and ALP changes with enzalutamide/radium-223 2025/06/16